Conti-Tronconi B M, Tang F, Diethelm B M, Spencer S R, Reinhardt-Maelicke S, Maelicke A
Department of Biochemistry, College of Biological Sciences, University of Minnesota, St. Paul 55108.
Biochemistry. 1990 Jul 3;29(26):6221-30. doi: 10.1021/bi00478a016.
Previous studies by several laboratories have identified a narrow sequence region of the nicotinic acetylcholine receptor (AChR) alpha subunit, flanking the cysteinyl residues at positions 192 and 193, as containing major elements of, if not all, the binding site for cholinergic ligands. In the present study, we used a panel of synthetic peptides as representative structural elements of the AChR to investigate whether additional segments of the AChR sequences are able to bind alpha-bungarotoxin (alpha-BTX) and several alpha-BTX-competitive monoclonal antibodies (mAbs). The mAbs used (WF6, WF5, and W2) were raised against native Torpedo AChR, specifically recognize the alpha subunit, and bind to AChR is inhibited by all cholinergic ligands. WF6 competes with agonists, but not with low mol. wt. antagonists, for AChR binding. The synthetic peptides used in this study were approximately 20 residue long, overlapped each other by 4-6 residues, and corresponded to the complete sequence of Torpedo AChR alpha subunit. Also, overlapping peptides, corresponding to the sequence segments of each Torpedo AChR subunit homologous to alpha 166-203, were synthesized. alpha-BTX bound to a peptide containing the sequence alpha 181-200 and also, albeit to a lesser extent, to a peptide containing the sequence alpha 55-74. WF6 bound to alpha 181-200 and to a lesser extent to alpha 55-74 and alpha 134-153. The two other mAbs predominantly bound to alpha 55-74, and to a lesser extent to alpha 181-200. Peptides alpha 181-200 and alpha 55-74 both inhibited binding of 125I-alpha-BTX to native Torpedo AChR. None of the peptides corresponding to sequence segments from other subunits bound alpha-BTX or WF6, or interfered with their binding. Therefore, the cholinergic binding site is not a single narrow sequence region, but rather two or more discontinuous sequence segments within the N-terminal extracellular region of the AChR alpha subunit, folded together in the native structure of the receptor, contribute to form a cholinergic binding region. Such a structural arrangement is similar to the "discontinuous epitopes" observed by X-ray diffraction studies of antibody-antigen complexes [reviewed in Davies et al. (1988)].
几个实验室之前的研究已确定,烟碱型乙酰胆碱受体(AChR)α亚基中,位于第192和193位半胱氨酸残基两侧的一个狭窄序列区域,即使不是全部,也包含胆碱能配体结合位点的主要元件。在本研究中,我们使用一组合成肽作为AChR的代表性结构元件,以研究AChR序列的其他片段是否能够结合α-银环蛇毒素(α-BTX)和几种α-BTX竞争性单克隆抗体(mAb)。所用的mAb(WF6、WF5和W2)是针对天然电鳐AChR产生的,特异性识别α亚基,并且与AChR的结合受到所有胆碱能配体的抑制。WF6与激动剂竞争AChR结合,但不与低分子量拮抗剂竞争。本研究中使用的合成肽长度约为20个残基,彼此重叠4-6个残基,并且对应于电鳐AChRα亚基的完整序列。此外,还合成了与每个电鳐AChR亚基中与α166-203同源的序列片段相对应的重叠肽。α-BTX与包含α181-200序列的肽结合,并且在较小程度上也与包含α55-74序列的肽结合。WF6与α181-200结合,在较小程度上与α55-74和α134-153结合。另外两种mAb主要与α55-74结合,在较小程度上与α181-200结合。肽α181-200和α55-74均抑制125I-α-BTX与天然电鳐AChR的结合。与其他亚基序列片段相对应的肽均不结合α-BTX或WF6,也不干扰它们的结合。因此,胆碱能结合位点不是单个狭窄的序列区域,而是AChRα亚基N端细胞外区域内两个或更多个不连续的序列片段,它们在受体的天然结构中折叠在一起,共同形成一个胆碱能结合区域。这种结构排列类似于通过抗体-抗原复合物的X射线衍射研究观察到的“不连续表位”[Davies等人(1988年)综述]。